Vital Signs - 12 June 2006
Vital Signs - 12 June 2006
RELEASE DATE
12-Jun-2006
12-Jun-2006
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: 9561-00-06-00-00
SKU: HC00438-NA-MR_03910
CN¥10,861.05
In stock
SKU
HC00438-NA-MR_03910
Description
This issue of Vital Signs, released on June 12, 2006, provides a strategic overview of the potential impact of patent expirations of blockbuster drugs and the resulting growth opportunity for generic drugs. Additionally, an emerging company profile is provided on Cell Genesys, a biotechnology company focused on the development and commercialization of cancer therapies. Reimbursement and regulatory news from the FDA and CMS are also provided for the week of May 30 - June 2, 2006.
Table of Contents
Patent Expirations and Opportunities for Generics
Popular Topics
This issue of Vital Signs, released on June 12, 2006, provides a strategic overview of the potential impact of patent expirations of blockbuster drugs and the resulting growth opportunity for generic drugs. Additionally, an emerging company profile is provided on Cell Genesys, a biotechnology company focused on the development and commercialization of cancer therapies. Reimbursement and regulatory news from the FDA and CMS are also provided for the week of May 30 - June 2, 2006.
Deliverable Type | Market Research |
---|---|
No Index | Yes |
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-06-00-00 |
Is Prebook | No |